Back to search
FDAFDA · Food and drugs·Recall number Z-1045-2022

Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 Test

Published May 18, 2022 · Recall initiated: April 9, 2022

Summary

FDA records medical device Class I recall Z-1045-2022, published May 18, 2022 and initiated April 9, 2022. Recalling firm: Woodside Acquisitions Inc.; Status: Ongoing; Reported quantity: 17,000 units; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Woodside Acquisitions Inc.
Distributor
US distributions to states of: AL and GA.
Lot
All lots
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 Test recalled?

Yes. FDA published recall Z-1045-2022 on May 18, 2022. Reported hazard: Firm distributed tests which have not been cleared or authorized for marketing or distribution in the United States.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail